<ul><li>Biostate AI, a deeptech startup, has raised $12 million in Series A funding led by Accel, with participation from other venture capital firms.</li><li>Founded by former professors David Zhang and Ashwin Gopinath, the startup aims to improve RNA sequencing for precision medicine by reducing costs and enhancing data quality using generative AI.</li><li>Biostate AI's platform has been employed in over 150 pilot projects, including collaborations with Cornell University and the Accelerated Cure Project, showcasing its potential in the field of molecular medicine.</li><li>The company's long-term goal is to transition from diagnostics to therapies, leveraging AI tools like Quantaquill and disease-specific predictive models to revolutionize healthcare.</li></ul>

Deeptech startup Biostate AI raises $12 million in led by Accel, others

Discover more